Skip Navigation
Skip to contents

ICDM 2025

Program details

Main symposia
Epidemiology and genetics 1 The future of diabetes management: data and AI-driven innovation Chair(s): Ji Oh Mok, Jae Hyoung Cho
Friday 26 September, 08:40~10:00
Room 3
(Walker hall 1, 1F)
This session highlights recent advancements in predicting and managing diabetic complications through innovative data-driven approaches and artificial intelligence. It covers topics ranging from predictive models using multi-center clinical data, multimodal AI integration of clinical and imaging data, to exploring the potential of large-scale language models in diabetes clinical practice. The session aims to discuss cutting-edge technologies and research outcomes poised to shape the future of diabetes management and enhance real-world clinical practices.
Hyunji Sang S13-L1
Hyunji SangKyung Hee University, Korea
Model for predicting diabetic complications using multi-center clinical data
Seong Jae Hwang S13-L2
Seong Jae HwangYonsei University, Department of Artificial Intelligence, Korea
Multimodal AI integrating clinical and imaging data in diabetes mellitus
Jaewoo Kang S13-L3
Jaewoo KangKorea University, Korea
Leveraging domain-specific language models for clinical decision support in diabetes
Panel discussion
  • Soo Jin Yun S13-P1
    Soo Jin YunKyung Hee University, Korea
  • Eun-Hee Cho S13-P2
    Eun-Hee ChoKangwon National University, Korea
  • Jeonghoon Lee S13-P3
    Jeonghoon LeeKakaoHealthcare Corp., Korea
Epidemiology and genetics 2 Genetic insights unraveling novel drug targets and underlying heterogeneity in diabetes Chair(s): Kyong Soo Park, Eun Seok Kang
Friday 26 September, 13:30~14:50
Room 3
(Walker hall 1, 1F)
This session explores cutting-edge advances in diabetes research, highlighting genetic, metabolomic, and proteomic insights into disease heterogeneity and drug target discovery. Speakers will discuss novel frameworks such as PIGEAN, the genetic basis of diabetes subtypes, and the promise of AI-driven approaches in therapeutic development. Together, these talks underscore the growing potential of precision medicine in transforming diabetes care.
Jason Flannick S12-L1
Jason FlannickBoston Children's Hospital, USA
Extending the concept genetic support for the involvement of genes in human disease
Alisa Manning S12-L2
Alisa ManningMassachusetts General Hospital, USA
Genetic dissection of heterogeneity in diabetes
Soo Heon Kwak S12-L3
Soo Heon KwakSeoul National University, Korea
Metabolomic and proteomic markers of diabetes
Hyunjin Shin S12-L4
Hyunjin ShinMOGAM Institute for Biomedical Research, Korea
Transforming drug discovery with AI: a future outlook in metabolic diseases
Epidemiology and genetics 3 Optimal strategies in older adults with diabetes Chair(s): Seok Won Park, Dong-Hyeok Cho
Saturday 27 September, 11:00~12:20
Room 3
(Walker hall 1, 1F)
This session provides a comprehensive overview of personalized care for older adults with diabetes, exploring current epidemiologic characteristics, optimal management of sarcopenia, and appropriate pharmacologic treatments. The session will culminate with the presentation of the new KDA position statement, offering an essential roadmap for clinicians to establish a standard of care for this growing and vulnerable population.
Ji Hye Heo S14-L1
Ji Hye HeoHallym University, Korea
Current epidemiologic and clinical characteristics of older adults with diabetes in Korea
Yoshitaka Hashimoto S14-L2
Yoshitaka HashimotoMatsushita Memorial Hospital, Japan
Optimal management for sarcopenia in older adults with diabetes
Hye Seung Jung S14-L3
Hye Seung JungSeoul National University, Korea
Optimal pharmacologic treatment strategies in older adults with diabetes
Jae-Seung  Yun S14-L4
Jae-Seung YunThe Catholic University of Korea, Korea
KDA position statement: recommendations for the optimal management of diabetes in older adults
KDA 대한당뇨병학회Korean Diabetes Association
  • (04146) 101-2104, Lotte Castle President, 109 Mapo-gu, Seoul, Korea
  • Tel: +82-2-714-9064 | E-mail: diabetes@kams.or.kr
  • Business Registration Number: 106-82-31108 | Name of Representative: Bong-Soo Cha
Congress Secretariat (Planbear)
  • #1108, 220, Gonghang-daero, Gangseo-gu, Seoul(07806), Republic of Korea
  • Tel. +82-2-6953-0582   E-mail: icdm@diabetes.or.kr